%global __brp_check_rpaths %{nil} %global __requires_exclude ^libmpi %global packname vaccine %global packver 1.2.1 %global rlibdir /usr/local/lib/R/library Name: R-CRAN-%{packname} Version: 1.2.1 Release: 1%{?dist}%{?buildtag} Summary: Statistical Tools for Immune Correlates Analysis of Vaccine Clinical Trial Data License: GPL (>= 3) URL: https://cran.r-project.org/package=%{packname} Source0: %{url}&version=%{packver}#/%{packname}_%{packver}.tar.gz BuildRequires: R-devel >= 2.10 Requires: R-core >= 2.10 BuildArch: noarch BuildRequires: R-utils >= 4.3.2 BuildRequires: R-methods >= 4.2.2 BuildRequires: R-splines >= 4.2.2 BuildRequires: R-stats >= 4.2.2 BuildRequires: R-CRAN-ggplot2 >= 3.4.0 BuildRequires: R-CRAN-survival >= 3.4.0 BuildRequires: R-CRAN-SuperLearner >= 2.0.28 BuildRequires: R-CRAN-e1071 >= 1.7.12 BuildRequires: R-CRAN-gam >= 1.22.3 BuildRequires: R-CRAN-fdrtool >= 1.2.17 BuildRequires: R-CRAN-Rsolnp >= 1.16 BuildRequires: R-CRAN-truncnorm >= 1.0.8 BuildRequires: R-CRAN-rlang >= 1.0.6 BuildRequires: R-CRAN-dplyr >= 1.0.10 BuildRequires: R-CRAN-ggpubr >= 0.5.0 BuildRequires: R-CRAN-simest >= 0.4 BuildRequires: R-CRAN-ranger >= 0.16.0 BuildRequires: R-CRAN-survML >= 0.0.0.9000 Requires: R-utils >= 4.3.2 Requires: R-methods >= 4.2.2 Requires: R-splines >= 4.2.2 Requires: R-stats >= 4.2.2 Requires: R-CRAN-ggplot2 >= 3.4.0 Requires: R-CRAN-survival >= 3.4.0 Requires: R-CRAN-SuperLearner >= 2.0.28 Requires: R-CRAN-e1071 >= 1.7.12 Requires: R-CRAN-gam >= 1.22.3 Requires: R-CRAN-fdrtool >= 1.2.17 Requires: R-CRAN-Rsolnp >= 1.16 Requires: R-CRAN-truncnorm >= 1.0.8 Requires: R-CRAN-rlang >= 1.0.6 Requires: R-CRAN-dplyr >= 1.0.10 Requires: R-CRAN-ggpubr >= 0.5.0 Requires: R-CRAN-simest >= 0.4 Requires: R-CRAN-ranger >= 0.16.0 Requires: R-CRAN-survML >= 0.0.0.9000 %description Various semiparametric and nonparametric statistical tools for immune correlates analysis of vaccine clinical trial data. This includes calculation of summary statistics and estimation of risk, vaccine efficacy, controlled effects (controlled risk and controlled vaccine efficacy), and mediation effects (natural direct effect, natural indirect effect, proportion mediated). See Gilbert P, Fong Y, Kenny A, and Carone, M (2022) and Fay MP and Follmann DA (2023) . %prep %setup -q -c -n %{packname} # fix end of executable files find -type f -executable -exec grep -Iq . {} \; -exec sed -i -e '$a\' {} \; # prevent binary stripping [ -d %{packname}/src ] && find %{packname}/src -type f -exec \ sed -i 's@/usr/bin/strip@/usr/bin/true@g' {} \; || true [ -d %{packname}/src ] && find %{packname}/src/Make* -type f -exec \ sed -i 's@-g0@@g' {} \; || true # don't allow local prefix in executable scripts find -type f -executable -exec sed -Ei 's@#!( )*/usr/local/bin@#!/usr/bin@g' {} \; %build %install mkdir -p %{buildroot}%{rlibdir} %{_bindir}/R CMD INSTALL -l %{buildroot}%{rlibdir} %{packname} test -d %{packname}/src && (cd %{packname}/src; rm -f *.o *.so) rm -f %{buildroot}%{rlibdir}/R.css # remove buildroot from installed files find %{buildroot}%{rlibdir} -type f -exec sed -i "s@%{buildroot}@@g" {} \; %files %{rlibdir}/%{packname}